Preclinical Evaluation of Bispecific Adaptor Molecule Controlled Folate Receptor CAR-T Cell Therapy With Special Focus on Pediatric Malignancies

Overview of attention for article published in Frontiers in oncology, March 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 9,925 followers.

Preclinical Evaluation of Bispecific Adaptor Molecule Controlled Folate Receptor CAR-T Cell Therapy With Special ... https://t.co/nSb9RBweqz

RT @OrentasR: Want to see what all the excitement is behind Endocyte’s small molecule universal CAR-T program? Check this out as an intro-…

RT @OrentasR: Want to see what all the excitement is behind Endocyte’s small molecule universal CAR-T program? Check this out as an intro-…

Want to see what all the excitement is behind Endocyte’s small molecule universal CAR-T program? Check this out as an intro- clinical trials coming soon @seattlechildren #Immunotherapy #CARTcells #FolateReceptor. https://t.co/2IZm3obgig

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.